Found: 27
Select item for more details and to access through your institution.
A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2024, v. 11, n. 9, p. 1103, doi. 10.1002/mdc3.14145
- By:
- Publication type:
- Article
Impact of the Dopamine System on Long‐Term Cognitive Impairment in Parkinson Disease: An Exploratory Study.
- Published in:
- Movement Disorders Clinical Practice, 2023, v. 10, n. 6, p. 943, doi. 10.1002/mdc3.13751
- By:
- Publication type:
- Article
Correction to: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01282-8
- By:
- Publication type:
- Article
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01282-8
- By:
- Publication type:
- Article
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 3, p. 312, doi. 10.1001/jamaneurol.2020.4725
- By:
- Publication type:
- Article
LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00468-2
- By:
- Publication type:
- Article
LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00468-2
- By:
- Publication type:
- Article
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00404-w
- By:
- Publication type:
- Article
Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 1, p. 201, doi. 10.1002/acn3.51269
- By:
- Publication type:
- Article
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 10, p. 1816, doi. 10.1002/acn3.51164
- By:
- Publication type:
- Article
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 4, p. 449, doi. 10.1002/acn3.51022
- By:
- Publication type:
- Article
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 12, p. 1460, doi. 10.1002/acn3.644
- By:
- Publication type:
- Article
Predictors of time to initiation of symptomatic therapy in early Parkinson's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2016, v. 3, n. 7, p. 482, doi. 10.1002/acn3.317
- By:
- Publication type:
- Article
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
- Published in:
- Acta Neuropathologica, 2016, v. 131, n. 6, p. 935, doi. 10.1007/s00401-016-1552-2
- By:
- Publication type:
- Article
Cognition among individuals along a spectrum of increased risk for Parkinson’s disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201964
- By:
- Publication type:
- Article
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
- Published in:
- Movement Disorders, 2015, v. 30, n. 10, p. 1371, doi. 10.1002/mds.26248
- By:
- Publication type:
- Article
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
- Published in:
- Movement Disorders, 2015, v. 30, n. 7, p. 919, doi. 10.1002/mds.26170
- By:
- Publication type:
- Article
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.
- Published in:
- PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0175674
- By:
- Publication type:
- Article